MARKET

PEPG

PEPG

PepGen Inc
NASDAQ
1.725
-0.035
-1.99%
Opening 14:16 05/11 EDT
OPEN
1.780
PREV CLOSE
1.760
HIGH
1.780
LOW
1.680
VOLUME
446.61K
TURNOVER
--
52 WEEK HIGH
7.80
52 WEEK LOW
1.010
MARKET CAP
119.32M
P/E (TTM)
-0.8124
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PEPG last week (0504-0508)?
Weekly Report · 7h ago
Weekly Report: what happened at PEPG last week (0427-0501)?
Weekly Report · 05/04 10:33
Weekly Report: what happened at PEPG last week (0420-0424)?
Weekly Report · 04/27 10:37
Weekly Report: what happened at PEPG last week (0413-0417)?
Weekly Report · 04/20 10:32
Tesla, Intel, IBM To Report Earnings Next Week
Seeking Alpha · 04/18 15:00
Catalyst Watch: Tesla talks AI5 chips, Intel reports, and the Warner Bros. deal goes to a vote
Seeking Alpha · 04/17 19:00
Weekly Report: what happened at PEPG last week (0406-0410)?
Weekly Report · 04/13 10:36
Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus
Seeking Alpha · 04/11 15:00
More
About PEPG
PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies. The Company’s Enhanced Delivery Oligonucleotide (EDO) platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake and nuclear delivery. Using these EDO peptides, the Company is generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases. It is focused on addressing the underlying cause of Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), which have high unmet need. Its pipeline consists of two clinical stage programs, PGN-EDO51 for DMD patients who are amenable to an exon 51-skipping approach and PGN-EDODM1 for DM1 patients, and several additional preclinical stage programs. Its product candidates also include PGN-EDO53, PGN-EDO45 and PGN-EDO44.

Webull offers PepGen Inc stock information, including NASDAQ: PEPG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PEPG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PEPG stock methods without spending real money on the virtual paper trading platform.